Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Single Marker Associations of Nuclear-Encoded Mitochondrial Genes with Advanced AMD

Go back to Resources

Single Marker Associations of Nuclear-Encoded Mitochondrial Genes with Advanced AMD

Authors:

Secondary:

Location:

Go back to Resources

Single Marker Associations of NFkB Pathway Genes with Advanced AMD

Go back to Resources

Single Marker Associations of NFkB Pathway Genes with Advanced AMD

Authors:

Secondary:

Location:

URL:

Go back to Resources

Single Marker Associations of Cell Cycle Pathway Genes with Advanced AMD

Go back to Resources

Single Marker Associations of Cell Cycle Pathway Genes with Advanced AMD

Authors:

Secondary:

Location:

Go back to Resources

Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults

Go back to Resources

Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults

Authors:

Secondary:

Location:

URL:

Go back to Resources

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

Go back to Resources

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Progression of Geographic Atrophy as Measured by Digital Area

Go back to Resources

Progression of Geographic Atrophy as Measured by Digital Area

Authors:

Secondary:

Location:

Go back to Resources

Phase I Clinical Evaluation of a Six-Plasmid Multiclade HIV-1 DNA Candidate Vaccine

Go back to Resources

Phase I Clinical Evaluation of a Six-Plasmid Multiclade HIV-1 DNA Candidate Vaccine

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Identifying Investigators to Conduct Randomized Controlled Trials (RCTs) in a Practice Based Research Network (PBRN)

Go back to Resources

Identifying Investigators to Conduct Randomized Controlled Trials (RCTs) in a Practice Based Research Network (PBRN)

Authors:

Secondary:

Go back to Resources

Exact Likelihood Ratio Trend Test Using Correlated Binary Data

Go back to Resources

Exact Likelihood Ratio Trend Test Using Correlated Binary Data

Authors:

Secondary:

Location:

URL:

Go back to Resources

Dietary Glycemic Index is Related to Progression of Age-Related Macular Degeneration

Go back to Resources

Dietary Glycemic Index is Related to Progression of Age-Related Macular Degeneration

Authors:

Secondary:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Current page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification